JACQUELYNN DORMAN: Open Payments
NPI 1962068981 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 14 payments from 4 companies in 2025. Trend: 2023 $949 · 2024 $660 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $191 |
| AstraZeneca Pharmaceuticals LP | 4 | $182 |
| Novo Nordisk Inc | 3 | $158 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
Products named: AIRSUPRA, TARPEYO, Ozempic, ZEPBOUND, MOUNJARO, Saxenda, Rybelsus.
Industry payments across TX — which companies pay providers there.
